Impact of RAS mutation status on early progression in patients with initially unresectable colorectal liver metastases undergoing conversion therapy: a retrospective analysis - Top-Institutions - MDSpire

Impact of RAS mutation status on early progression in patients with initially unresectable colorectal liver metastases undergoing conversion therapy: a retrospective analysis

  • By

  • Rong Yang

  • Weili Zhang

  • Jin Lan

  • Weihao Li

  • Zhigang Hong

  • Jun Chi

  • Jianhong Peng

  • Cong Li

  • Xiaojun Wu

  • July 1, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Oslo University Hospital
    Oslo University Hospital

    Oslo, Norway

    Key Differentiators

    • Oncology

  • #2

    Sun Yat-sen University Cancer Center
    Sun Yat-sen University Cancer Center

    Guangzhou, China

    Key Differentiators

    • Oncology

  • #3

    University of Oslo
    University of Oslo

    Oslo, Norway

    Key Differentiators

    • Oncology

  • #4

    City of Hope
    City of Hope

    Duarte, California

    Key Differentiators

    • Oncology

Original Source(s)

Impact of RAS mutation status on early progression in patients with initially unresectable colorectal liver metastases undergoing conversion therapy: a retrospective analysis

  • by Rong Yang, Weili Zhang, Jin Lan, Weihao Li, Zhigang Hong, Jun Chi, Jianhong Peng, Cong Li, Xiaojun Wu

  • July 1, 2026

Related Content

Risk of lymph-node metastasis in early onset T1 colorectal cancer: a systematic review and meta-analysis

Integrative single-cell and bulk transcriptomic analyses identify DRAM1 as a candidate gene from fibroblast-associated transcriptional programs in colorectal cancer

Comparative accuracy of spectral computed tomography and conventional computed tomography in colorectal cancer staging